Alpha Tau Medical Ltd.

NASDAQ: DRTS · Real-Time Price · USD
3.27
0.07 (2.19%)
At close: Aug 15, 2025, 3:59 PM
3.28
0.46%
After-hours: Aug 15, 2025, 04:10 PM EDT

Alpha Tau Medical Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
n/a n/a 1.07M 1.07M 1.59M 1.59M 1.49M 1.49M 979K 1.21M 1.01M 1.01M 1.01M 776K n/a n/a n/a
Gross Profit
n/a n/a -1.07M -1.07M -1.59M -1.59M -1.49M -1.49M -979K -1.21M -1.01M -1.01M -1.01M -776K n/a n/a n/a
Operating Income
-36.93M -36.04M -35.71M -36.35M -35.46M -35.68M -33.72M -32.16M -32M -32.14M -28.09M -24.37M -19.84M -13.79M -12.56M -11.64M -10.07M
Interest Income
n/a n/a n/a n/a n/a n/a 7.99K 12.73K 12.73K 12.73K 4.74K n/a n/a n/a n/a n/a 164.5K
Pretax Income
-32.36M -31.74M -29.63M -27.65M -28.95M -29.14M -25.18M -22.84M -16.17M -33.74M -34.14M -36.33M -41.31M -27.26M -25.88M -23.5M -18.48M
Net Income
-32.46M -31.75M -29.64M -27.63M -28.95M -29.16M -25.19M -22.9M -16.2M -33.76M -34.15M -36.32M -41.3M -27.27M -25.91M -23.54M -18.57M
Selling & General & Admin
9.18M 9.02M 8.73M 8.87M 8.89M 9.26M 9.41M 9.69M 10.04M 11.25M 9.36M 7.43M 5.34M 2.34M 2.1M 1.98M 1.87M
Research & Development
27.74M 27.02M 26.98M 27.48M 26.57M 26.42M 24.31M 22.47M 21.96M 20.89M 18.74M 16.94M 14.49M 11.45M 10.89M 10.54M 9.08M
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -4.69M -9.39M -14.08M
Operating Expenses
36.93M 36.04M 34.64M 35.27M 34.39M 34.61M 33.72M 32.16M 32M 32.14M 28.09M 24.37M 19.84M 13.79M 12.4M 11.33M 9.96M
Interest Expense
n/a n/a n/a n/a n/a n/a 7.97M 12.71M 18.73M 18.73M 24.58M 19.84M 13.82M 13.82M n/a n/a n/a
Selling & Marketing Expenses
2.27M 2.35M 2.11M 2.14M 2.06M 1.92M 1.87M 1.56M 1.17M 974K 703K 557K 523K 482K 428.5K 399K 383.5K
Cost & Expenses
36.93M 36.04M 35.71M 36.35M 35.46M 35.68M 33.72M 32.16M 32M 32.14M 28.09M 24.37M 19.84M 13.79M 12.4M 11.33M 9.96M
Income Tax Expense
104K 6K 12K -27K -4K 16K 11K 59K 39K 20K 3K -11K -2K 7K 27.5K 39K 96.5K
Shares Outstanding (Basic)
70.45M 70.09M 69.9M 69.87M 69.71M 69.67M 69.47M 69.32M 69.21M 69.11M 68.8M 68.43M 47.5M 47.5M 67.62M 67.62M 67.62M
Shares Outstanding (Diluted)
70.45M 70.09M 69.9M 69.87M 69.71M 69.67M 69.47M 69.32M 69.21M 69.11M 68.8M 68.43M 47.5M 47.5M 67.62M 67.62M 67.62M
EPS (Basic)
-0.47 -0.46 -0.43 -0.4 -0.42 -0.43 -0.37 -0.34 -0.24 -0.66 -0.69 -0.72 -0.79 -0.42 -0.4 -0.4 -0.34
EPS (Diluted)
-0.47 -0.46 -0.43 -0.4 -0.42 -0.43 -0.37 -0.34 -0.24 -0.66 -0.69 -0.72 -0.79 -0.42 -0.4 -0.4 -0.34
EBITDA
-32.05M -30.89M -34.09M -34.48M -33.86M -34.1M -27.65M -26.08M -25.7M -25.85M -22.75M -19.08M -14.6M -8.62M -11.99M -11.24M -9.84M
EBIT
-32.33M -31.44M -35.71M -36.35M -35.96M -36.18M -34.22M -32.65M -32M -32.14M -28.09M -24.37M -19.84M -13.79M -12.56M -11.64M -10.07M
Depreciation & Amortization
280K 548.5K 1.62M 1.87M 2.1M 2.08M 1.98M 1.98M 1.71M 1.7M 1.5M 1.44M 1.39M 1.32M 566K 401K 231K